After the challenges of 2020 with the Covid-19 pandemic, this is the unmissable event that the pharmaceutical, biotechnology, and medical device communities need to come together and discuss strategies for […]

SMi are proud to announce the 7th annual conference: Pre-Filled Syringes East Coast 2020 26-27 October 2020 Boston, USA Sheraton Boston Hotel http://www.pfsamericas.com/pjwl Innovations in parenteral device and product development SMi […]

Smithers’ 9th annual Extractables and Leachables USA conference is returning. This is a unique event in the extractables and leachables industry, bringing together top companies from the entire supply chain and making […]

Priming the immune system against solid tumors by leveraging immune checkpoint blockade has proven to be an effective tool in multiple malignancies. Following the success of PD1/PDL1 checkpoint inhibitors a […]

Realise the Commercial Potential of Gene Therapies The 4th Annual Gene Therapy for Rare Disorders Europe is dedicated to overcoming manufacturing, clinical, and commercialisation challenges drug developers face when delivering gene therapies to market. With new European […]

Priming the immune system against solid tumors by leveraging immune checkpoint blockade has proven to be an effective tool in multiple malignancies. Following the success of PD1/PDL1 checkpoint inhibitors a […]

Harnessing the Potential of Macrophage Therapies Using Small Molecule, Antibody & Cell Therapy based Approaches for Oncology and Beyond With the explosive excitement and clinical proof of concepts utilizing CD47 […]

SMi’s 3rd Annual Pharmaceutical Microbiology East Coast Conference: 28 – 29 October 2020 Location: Virtual Event Website: www.microbiologyeastcoast.com/PJWL SPONSORED BY: Associates of Cape Cod, bioMérieux, Bioscience International, C.T.L. MAT, LONZA CHAIRED BY: Lynne Ensor,VP Technical, […]

Finding new therapeutics to counter the progression of Dry AMD and prevent the geographical atrophy has never been more important. The aging population creates an ever-growing clinical need for next-generation […]

Achieving Standardization & Operational Excellence in Vein-to-Vein Supply As an increasing number of candidates enter the clinic and promise to be a mainstay in the future of cancer treatment, cell […]

With all eyes on the explosive neoantigen field watching to see how it can revolutionize cancer immunotherapies and rival the current T cell therapies, it is clear that critical questions […]

This forum has a long-standing reputation for bringing together leading academic and industry microbiome researchers. Presentations will feature the latest research into the human microbiome as well as effective business […]

This congress will explore the burgeoning field of skin microbiome research, with case studies focused on topics such atopic dermatitis, psoriasis, acne, and allergy, and the microbiome-based products being developed […]

This Congress will include numerous presentations on probiotics discovery and product development, as well as prebiotics, diet and nutrition. Alongside several case studies on digestive health, metabolic diseases, ageing and […]

The 3rd Lab Asset & Facility Management in Pharma will return to Boston this Winter as your ONLY industry led meeting focusing on R&D asset and FM, enabling you to regain control of […]

The 3rd Annual Neuropsychiatric Drug Development Summit will return in November 2020 as an interactive, virtual meeting. This definitive industry meeting is focused on helping you develop the next generation […]

Europe's #1 forum for oligonucleotide, peptide, CRISPR and mRNA therapeutic leaders to discuss scientific strategies and accelerate products to market, while also creating new successful partnerships. This year's virtual agenda features 5 scientific tracks covering in-depth development strategies, trends and technologies across the entire oligonucleotide and peptide spectrum; as well as a partnering track that […]

The Digital 2nd Annual Biomarkers for Rare Non-Oncological Diseases Summit will unite biopharma, diagnostic and healthcare teams to advance the application of precision medicine in rare diseases beyond oncology. This event is completely free for Drug Developers, Researchers and Academics. To register your complimentary pass, simply follow this link: www.nononcologyraredisease-summit.com/take-part/register/ Tackling critical challenges from early research through to […]

2019 proved to be a pivotal year for the skin microbiome, as personal care giants Unilever launched their Dove range of ‘microbiome-friendly’ skincare products. Clearly, the biggest players in beauty and personal care have recognised the potential commercial value of skin microbiome-based consumer product claims and formulations. Moving forward into 2021, the market will continue […]

The exosome therapeutics field is booming with anticipation as preparations are underway for the first few clinical trials and money pours in through partnerships and pipeline acquisitions. However, more is needed to be done to uncover more scientific knowledge, fine-tune manufacturing methods and prepare trials to meet regulatory expectations. Considering this, the 2nd Digital Exosome Based Therapeutic Development Summit (November […]

Microbiome Connect: Human EU has been postponed this year due to the impacts of COVID-19.  However, at Microbiome Connect, we’re committed to continue providing a platform for scientific presentations and networking opportunities for the microbiome community before we return to face-to-face again in 2021. This November, we’ll be running a free-to-attend virtual symposium highlighting some […]

This Summit is designed to create a collaborative environment in which attendees engaged with the speakers, sponsors and other delegates in attendance. The meeting agenda has expanded to include: AI for genomics, single-cell analysis and target validation. AI for predicting patient response. AI impacting clinical trials. AI for imaging. AI for cancer immunotherapy and neurodegenerative […]

This Summit will focus its attention to some of the leading issues in Medicinal Chemistry today. This year the conference has expanded its coverage on protein degradation and will have a dedicated track running across both days to explore the cutting-edge research taking place in this exciting area. The integration of AI and machine learning […]

With about 85% of the proteome currently undrugged, accessing these targets that are, at present, extremely difficult to drug, has prevented researchers from achieving desired clinical successes. The 2nd Proteome- Targeted Drug Discovery Summit will unite large pharma and innovative biotech, as well as key opinion leaders in academia, to develop robust structural and biochemical […]

Solving the Translational Drug Development Gap, From Fibrotic Mechanisms to Clinically Effective Therapeutics. Now in its 4th year, the digital AFDD summit is the industry’s definitive guide to turning mechanistic understanding of fibrosis into clinically effective therapeutics across disease areas. With 3 days of in-depth cutting-edge case studies and the highest calibre of discussions from […]

The 3rd Lifecycle Management for Combination Products Summit is the only dedicated meeting focusing on Lifecycle Management (LCM) and perfecting design control. This year the meeting will unite senior combination products leaders online to discuss strategies and lessons learned to help you ensure commercial competitiveness in the combination product markets. From quality and product development, […]

As the industry grapples with unprecedented challenges, join us for our first ever Clinical Operations in Oncology Trials USA Virtual Experience brought to you directly in the comfort of your home! Bringing together experts from across the country to discuss the latest innovations in technology, regulatory affairs as well as discover new opportunities through adaptive […]

Discover the Next Generation of CRISPR Tools to Enhance Specificity, Reduce Off-Target Effects & Transform Gene Editing into a Clinical Reality CRISPR is one of the most powerful discoveries of the last decade. In a remarkably short space of time, ‘classic’ CRISPR-Cas9 has established itself as a reliable tool in the genomics toolbox, which leads […]

This meeting has a reputation for providing an outstanding networking experience. Discover how to effectively harness gains such as reducing lab costs, improving links with other laboratories and scientists, and minimizing human error. Topics covered on the agenda include: How AI is being applied to primary diagnosis and clinical research. AI for image analysis and […]